全文获取类型
收费全文 | 2837篇 |
免费 | 315篇 |
国内免费 | 30篇 |
专业分类
耳鼻咽喉 | 32篇 |
儿科学 | 85篇 |
妇产科学 | 63篇 |
基础医学 | 367篇 |
口腔科学 | 47篇 |
临床医学 | 309篇 |
内科学 | 551篇 |
皮肤病学 | 63篇 |
神经病学 | 268篇 |
特种医学 | 85篇 |
外科学 | 437篇 |
综合类 | 68篇 |
一般理论 | 2篇 |
预防医学 | 303篇 |
眼科学 | 48篇 |
药学 | 315篇 |
肿瘤学 | 139篇 |
出版年
2021年 | 40篇 |
2020年 | 26篇 |
2019年 | 47篇 |
2018年 | 56篇 |
2017年 | 37篇 |
2016年 | 45篇 |
2015年 | 52篇 |
2014年 | 54篇 |
2013年 | 91篇 |
2012年 | 111篇 |
2011年 | 132篇 |
2010年 | 82篇 |
2009年 | 60篇 |
2008年 | 118篇 |
2007年 | 144篇 |
2006年 | 117篇 |
2005年 | 124篇 |
2004年 | 108篇 |
2003年 | 101篇 |
2002年 | 124篇 |
2001年 | 113篇 |
2000年 | 108篇 |
1999年 | 70篇 |
1998年 | 46篇 |
1997年 | 46篇 |
1996年 | 35篇 |
1995年 | 37篇 |
1994年 | 29篇 |
1993年 | 43篇 |
1992年 | 58篇 |
1991年 | 73篇 |
1990年 | 65篇 |
1989年 | 72篇 |
1988年 | 64篇 |
1987年 | 58篇 |
1986年 | 55篇 |
1985年 | 55篇 |
1984年 | 50篇 |
1983年 | 35篇 |
1982年 | 18篇 |
1981年 | 18篇 |
1979年 | 28篇 |
1978年 | 24篇 |
1977年 | 31篇 |
1976年 | 24篇 |
1975年 | 27篇 |
1974年 | 31篇 |
1973年 | 28篇 |
1972年 | 16篇 |
1968年 | 18篇 |
排序方式: 共有3182条查询结果,搜索用时 0 毫秒
1.
2.
Growth hormone (GH) pulses in vivo are associated with increased hypothalamic portal growth hormone releasing hormone (GH-RH) concentration and can be prevented by GH-RH antisera. GH pulses are also associated with prior reduction of portal somatostatin (SRIF) concentrations, although SRIF antisera do not abolish GH pulses. In vitro, pulses of GH-RH as well as SRIF withdrawal are followed by pulses of GH release; the presence of GH-RH enhances post-SRIF GH release. We asked four questions: (1) During combined GHRH-SRIF exposure in vitro, must SRIF withdrawal be complete to produce a pulse of GH release, or is there a threshold diminution of SRIF which permits it? (2) When pulsatile GH release does occur, is it an all-or-none phenomenon, or is it titratable by fractional reduction of SRIF? (3) Does varying the GH-RH concentration while administering SRIF systematically alter GH release in response to fractional SRIF reduction? (4) Given a small but distinct effect of GH-RH on release of stored prolactin (PRL) in this system, does fractional SRIF reduction alter PRL release in parallel? Rat pituitary tissue whose hormone stores had been prelabeled with tritium was perifused for 120 min in combined 25 nM SRIF and 3 or 10 nM rat GH-RH (rGH-RH). Then, while maintaining rGH-RH concentrations, the SRIF concentration was left unchanged (control) or was reduced to 20, 15, 10, 5, or 0 nM for 60 min. Release of stored rGH and rPRL was assessed by immunoprecipitation.(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献
3.
4.
Anaerobic pathogenesis: collagenase production by Peptostreptococcus magnus and its relationship to site of infection. 总被引:3,自引:0,他引:3
C J Krepel C M Gohr C E Edmiston S G Farmer 《The Journal of infectious diseases》1991,163(5):1148-1150
Fifty isolates of Peptostreptococcus magnus from intraabdominal sepsis, nonpuerperal breast abscess, and diabetic foot infections were examined for collagenase activity using bovine type I collagen. Collagenase production was detected in a higher percentage of strains from nonpuerperal breast and diabetic foot specimens (P less than .001). This enzyme may be responsible for P. magnus playing a more central role in the pathogenesis of nonpuerperal breast abscess and diabetic foot disease than in intraabdominal sepsis. 相似文献
5.
CA von Arnim R Spoelgen ID Peltan M Deng S Courchesne M Koker T Matsui H Kowa SF Lichtenthaler MC Irizarry BT Hyman 《The Journal of neuroscience》2006,26(39):9913-9922
The beta-amyloid (Abeta) precursor protein (APP) is cleaved sequentially by beta-site of APP-cleaving enzyme (BACE) and gamma-secretase to release the Abeta peptides that accumulate in plaques in Alzheimer's disease (AD). GGA1, a member of the Golgi-localized gamma-ear-containing ARF-binding (GGA) protein family, interacts with BACE and influences its subcellular distribution. We now report that overexpression of GGA1 in cells increased the APP C-terminal fragment resulting from beta-cleavage but surprisingly reduced Abeta. GGA1 confined APP to the Golgi, in which fluorescence resonance energy transfer analyses suggest that the proteins come into close proximity. GGA1 blunted only APP but not notch intracellular domain release. These results suggest that GGA1 prevented APP beta-cleavage products from becoming substrates for gamma-secretase. Direct binding of GGA1 to BACE was not required for these effects, but the integrity of the GAT (GGA1 and TOM) domain of GGA1 was. GGA1 may act as a specific spatial switch influencing APP trafficking and processing, so that APP-GGA1 interactions may have pathophysiological relevance in AD. 相似文献
6.
7.
David M Spiegel Beverly Farmer Gerard Smits Michel Chonchol 《Journal of renal nutrition》2007,17(6):416-422
OBJECTIVE: This study was designed to evaluate the efficacy of magnesium carbonate as a phosphate binder in hemodialysis patients. DESIGN: This study was a prospective, randomized, open-label trial comparing magnesium carbonate/calcium carbonate versus calcium acetate as a sole phosphate binder. SETTING: This study involved outpatient hemodialysis. PARTICIPANTS: We recruited 30 stable hemodialysis patients without a history of frequent diarrhea. INTERVENTION: After receiving informed consent, we randomized patients 2:1 to magnesium carbonate versus calcium acetate. The dose of each binder was titrated to achieve the Kidney Disease Outcomes Quality Initiative (K/DOQI) phosphate target of <5.5 mg/dL. MAIN OUTCOME MEASURE: The efficacy-phase serum phosphorus concentration and the percentage of patients meeting K-DOQI targets for phosphorus, along with the daily elemental calcium intake, were the primary outcome measures. RESULTS: Magnesium carbonate provided equal control of serum phosphorus (70.6% of the magnebind group and 62.5% of the calcium acetate group had their average serum phosphorus within the K-DOQI target during the efficacy phase), while significantly reducing daily elemental calcium ingestion from phosphate binders (908 +/- 24 vs. 1743 +/- 37 mg/day, P < .0001). CONCLUSION: Magnesium carbonate was generally well-tolerated in this selected patient population, and was effective in controlling serum phosphorus while reducing elemental calcium ingestion. 相似文献
8.
The reduction of methemoglobin levels by antioxidants 总被引:1,自引:0,他引:1
Preventing the oxidation of hemoglobin in solution is one of the major requirements for the successful production and long-term storage of hemoglobin-based blood substitutes. To this end we have studied the effects of antioxidants on the rate of methemoglobin formation and disappearance in solutions of human and bovine hemoglobin at 4 degrees C and 37 degrees C. Ascorbate and desferal (5 mM) were observed to act as prooxidants, increasing the rate of methemoglobin formation at 37 degrees C. Trehalose, mannitol, glucose, and EDTA (5 mM) had no significant effect. Glutathione and NADH (10 mM) were the most effective antioxidants tested, causing a significant decrease in the rate of methemoglobin formation at 37 degrees C for periods of up to 50 hours. The combination of these antioxidants in bovine hemoglobin at 4 degrees C resulted in the reduction of methemoglobin levels to nearly undetectable levels in approximately 150 hours. In addition, NADH and glutathione were found to reduce methemoglobin levels to 10% over a period of 100 hours in a sample of human hemoglobin that had been stored at 4 degrees C for one year and had 60% methemoglobin. These results suggest that the prevention and reversal of methemoglobin formation during the long-term storage of hemoglobin solutions and hemoglobin-based blood substitutes may now be possible. 相似文献
9.
A representative sample of 1,367 employed men and women in Detroit responded to questions about drinking practices and symptoms of depression. After controlling for age, education, family income, marital status, medication use, fathers' drinking, and other variables, increased quantity of alcohol consumed per drinking occasion was associated with increased depression symptoms in the sober state among men and women. Depression symptoms may be one of a group of not fully identified drug after-effect disorders involving psychological functioning. 相似文献
10.
Seid Hossein Mir-Madjlessi MD FACP Dr. Richard G. Farmer MD FACP Michael V. Sivak Jr MD FACP 《Digestive diseases and sciences》1987,32(2):145-154
Six cases of bile duct carcinoma were encountered among 1207 patients with ulcerative colitis, a prevalence rate of 0.5%. The relative risk of bile duct carcinoma in patients with ulcerative colitis was 31.3. Colitis was extensive in all six patients with a mean duration of 23.2 years before the diagnosis of carcinoma. The mean age at the diagnosis of carcinoma was 38.5 years. Three patients had undergone colectomy 5–16 years earlier, and in four patients pericholangitis and sclerosing cholangitis preexisted. The tumors, histologically adenocarcinomas, were located in the common bile duct in five patients and in the hepatic duct in one. The mean survival was 11.8 months (one patients is still alive with recurrent carcinoma). Pericholangitis and sclerosing cholangitis is a frequent preexisting lesion in patients with bile duct carcinoma complicating ulcerative colitis and may be considered a premalignant lesion in these patients. Both sclerosing cholangitis and bile duct carcinoma are rare in Crohn's disease. 相似文献